Financials
- Market Capitalization 590.72 M
- Employee 196
- Founded 2013
- CEO N/A
- Website www.4dmoleculartherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QG40R88
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.1
Rapporto prezzo/fatturato
5.1
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2789 | MDXG MiMedx Group, Inc - Common Stock | 4.08 USD | -0.73% | -0.24% | +11.78% | -34.82% | 607.70 M USD | ||
| 2794 | NGNE Neurogene Inc. - Common Stock | 38.32 USD | -3.31% | +16.16% | +30.61% | +30.25% | 605.53 M USD | ||
| 2820 | ALT Altimmune, Inc. - Common Stock | 2.99 USD | -1.97% | -2.92% | +14.12% | -30.30% | 581.48 M USD | ||
| 2824 | DRUG Bright Minds Biosciences Inc. - common stock | 75.93 USD | -2.45% | +11.88% | +22.76% | +192.49% | 579.79 M USD |